CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 184 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 7.73 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $166,956,377 | +66.0% | 4,345,559 | 0.0% | 9.97% | +36.9% |
| Q1 2023 | $100,599,691 | -11.6% | 4,345,559 | 0.0% | 7.28% | +2.9% |
| Q4 2022 | $113,853,646 | +35.8% | 4,345,559 | +1.9% | 7.08% | +9.6% |
| Q3 2022 | $83,861,000 | +33.4% | 4,265,559 | +18.7% | 6.46% | +8.8% |
| Q2 2022 | $62,877,000 | +41.7% | 3,595,026 | +32.6% | 5.93% | +56.9% |
| Q1 2022 | $44,369,000 | – | 2,712,041 | – | 3.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $198,319,737 | 34.81% |
| Saturn V Capital Management LP | 524,811 | $20,163,239 | 11.18% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $166,956,377 | 9.97% |
| Altium Capital Management LP | 305,000 | $11,718,100 | 8.87% |
| MPM BioImpact LLC | 1,003,406 | $38,550,859 | 7.76% |
| Affinity Asset Advisors, LLC | 321,017 | $12,333,473 | 4.31% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,131,000 | $81,873,020 | 3.69% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,748,141 | $67,163,577 | 3.59% |
| Nan Fung Group Holdings Ltd | 113,950 | $4,377,959 | 2.80% |
| Vivo Capital, LLC | 934,879 | $35,918,051 | 2.48% |